Impact Factor: 12.384
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. ARD is the official journal of EULAR.
Impact Factor: 12.384 (Number 1 journal in the Rheumatology category)
New: Welcome to the first Annals of the Rheumatic Diseases (ARD) podcast. In this podcast, Marie Kostine (France) and Laura Cappelli (Johns Hopkins University, Baltimore, USA) discuss onco and immuno-oncology, the main subject of the paper 'Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab', which was recently published by ARD.
ARD publishes summaries for patients and non-clinicians that clearly explain the findings and treatment implications arising from key research papers published in the journal. They are checked for accuracy and readability by the ARD editors and patient reviewers from PARE, and are free to access.
Just published: EULAR Textbook on Musculoskeletal Ultrasound in Rheumatology.